-
1
The metabolic model of heart failure: the role of sodium glucose co-transporter-2 (SGLT-2) inhibition
Published 2018-11-01Subjects: “…SGLT-2 inhibitors…”
Get full text
Article -
2
Three Levels of Disease Modification with SGLT-2 Inhibitors: Holy Grail in Vasculopathy
Published 2023-07-01Subjects: “…Hyperglycemia, SGLT-2, Inhibitors.…”
Get full text
Article -
3
Ketoacidosis without significantly hyperglycaemia - is it possible?
Published 2017-06-01Subjects: “…SGLT2 inhibitors…”
Get full text
Article -
4
Sodium–glucose cotransporter‐2 inhibitors induced euglycemic diabetic ketoacidosis: Two case reports and a review of the literature
Published 2022-02-01Subjects: Get full text
Article -
5
An Overview of the Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Hematological Parameters in Diabetic Patients
Published 2023-06-01Subjects: “…sglt2 inhibitors…”
Get full text
Article -
6
Unmasking of normocalcemic primary hyperparathyroidism after sodium-glucose cotransporter-2 inhibitor initiation
Published 2025-01-01Subjects: “…sglt2 inhibitors…”
Get full text
Article -
7
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis
Published 2021-05-01Subjects: “…SGLT2 inhibitors…”
Get full text
Article -
8
Is GFR decline induced by SGLT2 inhibitor of clinical importance?
Published 2024-05-01Subjects: Get full text
Article -
9
Euglycemic Diabetic Ketoacidosis in a Type 2 Diabetic Patient Treated with Empagliflozin: Case Report
Published 2023-10-01Subjects: “…sglt2 inhibitors…”
Get full text
Article -
10
Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives
Published 2019-02-01Subjects: “…SGLT2 inhibitors…”
Get full text
Article -
11
The Association of SGLT-2 inhibitors (Empagliflozin) with the development of hypernatremic dehydration: a case report
Published 2025-10-01Subjects: “…sglt-2 inhibitors…”
Get full text
Article -
12
SGLT-2 inhibitors in heart failure: a literature review on mechanisms, efficacy and safety
Published 2024-07-01Subjects: “…SGLT-2 inhibitors…”
Get full text
Article -
13
Clinical Evaluation of Dapagliflozin in the Management of CKD: Focus on Patient Selection and Clinical Perspectives
Published 2022-11-01Subjects: Get full text
Article -
14
Flozins in Reducing Cardiovascular and Metabolic Risk: A Literature Review
Published 2024-07-01Subjects: “…SGLT2-inhibitors…”
Get full text
Article -
15
Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Transcription Regulation of <i>AgRP</i> and <i>POMC</i> Genes
Published 2024-07-01Subjects: “…SGLT2 inhibitors…”
Get full text
Article -
16
SGLT2-Inhibitors - significant role in Heart Failure treatment
Published 2024-05-01Subjects: Get full text
Article -
17
Effects of SGLT2 inhibition on lipid transport in adipose tissue in type 2 diabetes
Published 2022-04-01Subjects: “…sglt2 inhibitors…”
Get full text
Article -
18
Effects of empagliflozin on reproductive system in men without diabetes
Published 2024-06-01Subjects: Get full text
Article -
19
Acute effects of dapagliflozin on renal oxygenation and perfusion in type 1 diabetes with albuminuria: A randomised, double-blind, placebo-controlled crossover trial
Published 2021-07-01Subjects: “…SGLT2 inhibitors…”
Get full text
Article -
20
The protective role of SGLT2 inhibitors on aortic aneurysm mediated by oxidative stress and inflammation in type 2 diabetes mellitus
Published 2025-02-01Subjects: “…SGLT2 inhibitors…”
Get full text
Article